FERROLAB

This brand name is authorized in Nigeria.

Active ingredients

The drug FERROLAB contains one active pharmaceutical ingredient (API):

1	Ferrous fumarate UNII R5L488RY0Q - FERROUS FUMARATE
	Ferrous fumarate is an easily absorbed source of iron for replacement therapy. It is a salt of ferrous iron with an organic acid and is less irritant to the gastro-intestinal tract than salts with inorganic acids. Iron and iron salts should be given for the treatment or prophylaxis of iron deficiency anaemias.
	Read more about Ferrous fumarate

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-5887	Capsule	FERROLAB 12 CAPSULE CAP 200 mg 33CL PET BOTTLE	102 RNW-PP-286671 FERROLAB 12 CAPSULE EACH CAPSULE CONTAINS PELLETS OF; FERROUS FUMARATE BP 200MG EQ. TO ELEMENTAL IRON 65MG, VITAMIN B13 BP 100MCG, FOLIC ACID BP 1000MCG, EXPCIPIENTS Q.S Apr-87 Drugs Imported Products 33CL PET BOTTLE 9/30/2022 EMBASSY PHARMACEUTICAL AND CHEMICALS LIMITED, 41,ADEMOLA STREET S.W IKOYI 14630021 embapharm_caredesk@yahoo.com LABORATE PHARMACEUTICALS INDIA LTD, 51,INDUSTRIAL AREA, GONDPUR PAONTA SAHIB (H.P.), INDIA	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AA02	Ferrous fumarate	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AA Iron bivalent, oral preparations
Discover more medicines within B03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-5887